Detoxification From the Lipid Tract

PHASE4CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

February 26, 2024

Primary Completion Date

March 14, 2024

Study Completion Date

March 20, 2024

Conditions
COVID-19 Vaccine Adverse Reaction
Interventions
DEVICE

electroencephalogram biofeedback

EB is conducted for 20 minutes per section with two sections per day in the primary efficacy endpoint.

DEVICE

electrical brain stimulation

EBS is conducted for 20 minutes per section per day in the primary efficacy endpoint.

DEVICE

ultra-low frequency transcranial magnetic stimulation

ULF-TMS is conducted mainly for the left side of the participant's brain for 20 minutes per section per day in the primary efficacy endpoint.

DRUG

Sertraline Hydrochloride

Sertraline is taken in the morning for 150 mg per day.

DRUG

Clonazepam

Clonazepam is taken in the morning for 1 mg per day.

DRUG

Alprazolam

Alprazolam is introduced near the end of the primary efficacy endpoint for 0.4 mg per night.

DRUG

Metoprolol

Metoprolol is introduced at the secondary efficacy endpoint starting with 47.5 mg per night and increase to 95 mg per night.

DRUG

Olanzapine

Olanzapine is taken throughout the trial with 7.5 mg per night at first, and increases to 10 mg per night after the cocktail therapy.

DRUG

Pravastatin Sodium 20 MG

Pravastatin sodium is introduced in the secondary efficacy endpoint with 20 mg per night.

DRUG

Sacubitril Valsartan Sodium Hydrate

Sacubitril valsartan sodium is introduced in the secondary efficacy endpoint with 100 mg per day.

Trial Locations (1)

402762

Residential Address, Chongqing

All Listed Sponsors
collaborator

First Affiliated Hospital of Chongqing Medical University

OTHER

lead

Pachankis, Yang I., M.D.

INDIV

NCT06357104 - Detoxification From the Lipid Tract | Biotech Hunter | Biotech Hunter